https://www.centre.care/services-1/dr.-joseph-a.-de-leo%2C-ph.d.%2C-c.psych.%2C-is-a-dual-licensed-clinical-and-rehabilitation-psychologist-in-ontario%2C-canada-and-new-york-state%2C-usa.-as-the-founder-and-clinical-director-of-the-centre-for-compassionate-care-(c3)%2C-joseph-and-his-team-are-deeply-committed-to-establishing-best-practices-and-standards-of-care-in-the-provisioning-of-psychedelic-assisted-psychotherapy.-as-a-clinician%2C-joseph-specializes-in-the-assessment-and-treatment-of-complex-mental-health-conditions%2C-including-addictions%2C-trauma%2C-and-chronic-pain.-he-has-extensive-experience-working-in-a-variety-of-clinical-settings%2C-including-hospital-based-programs-and-community-based-practices%2C-and-is-involved-in-clinical-teaching%2C-training%2C-and-supervision-initiatives-within-healthcare-organizations-and-universities-alike.---joseph-has-completed-specialized-training-in-psychedelic-assisted-therapies-and-research%2C-most-notably-at-the-california-institute-of-integral-studies-(ciis)%2C-maps-based-mdma-assisted-psychotherapy-for-ptsd%2C-as-well-as-through-ongoing-mentorship-and-consultation-in-ketamine-assisted-psychotherapy-with-local-practitioners-and-culturally-diverse-peer-groups.-along-with-dr.-mitch-earleywine%2C-he-is-the-co-developer-of-integrative-ketamine-enhanced-psychotherapy-(ikep)-for-difficult-to-treat-mental-health-conditions%2C-including-depressive%2C-trauma--and-stressor-related-disorders-(i.e.%2C-ptsd).----joseph-has-specific-interests-in-advocacy-that-focuses-on-the-safe-and-compassionate-use-of-psychoactive-plants-and-psychedelic-medicines%2C-including-therapeutic-cannabis-and-psilocybin.-as-an-author-and-consumer-of-clinical-and-psychological-research%2C-joseph-and-his-team-actively-engage-in-scholarship%2C-policy-discussions%2C-and-clinical-research-practices-that-promote-client-centered%2C-person-focused%2C-trauma-and-culturally-informed-evidence-based-care-models-that-can-broaden-access-to-effective-mental-health-treatments. 2024-06-24